| Pseudohallucinations associated with moclobemide: a case report. | |
| | |
MedLine Citation:
|
PMID: 16025422 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The goal of the multicenter drug surveillance project AMSP ("Arzneimittelsicherheit in der Psychiatrie") is the monitoring, assessment and analysis of adverse drug reactions (ADR) of psychopharmalogical drugs. We report about a 23 year-old patient with a depressive episode. He developed severe pseudohallucinations under a treatment with moclobemide. The symptoms occur 6 days after starting the medication and decline within two days after stopping moclobemide. The term "pseudohallucinations" is discussed controversially but still of high interest. |
| | |
Authors:
|
D Degner; S Kropp; J Porzig; R Grohmann; E Rüther |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Pharmacopsychiatry Volume: 38 ISSN: 0176-3679 ISO Abbreviation: Pharmacopsychiatry Publication Date: 2005 Jul |
Date Detail:
|
Created Date: 2005-07-18 Completed Date: 2005-08-26 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8402938 Medline TA: Pharmacopsychiatry Country: Germany |
Other Details:
|
Languages: eng Pagination: 179-81 Citation Subset: IM |
Affiliation:
|
Department of Psychiatry and Psychotherapy, Georg-August University of Göttingen, Germany. ddegner@gwdg.de |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Antidepressive Agents / adverse effects*, therapeutic use Depressive Disorder / complications, drug therapy Hallucinations / chemically induced*, physiopathology, psychology Humans Male Mianserin / analogs & derivatives, therapeutic use Moclobemide / adverse effects*, therapeutic use Monoamine Oxidase Inhibitors / adverse effects*, therapeutic use Sertraline / therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Antidepressive Agents; 0/Monoamine Oxidase Inhibitors; 24219-97-4/Mianserin; 61337-67-5/mirtazapine; 71320-77-9/Moclobemide; 79617-96-2/Sertraline |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Clioquinol treatment in familiar early onset of Alzheimer's disease: a case report.
Next Document: Citalopram therapy as a risk factor for symptomatic hyponatremia caused by the syndrome of inappropr...